User:Mr. Ibrahem/Deferoxamine

Deferoxamine (DFOA), sold under the brand name Desferal, is a medication that binds iron and aluminium. It is specifically used in iron overdose, hemochromatosis either due to multiple blood transfusions or an underlying genetic condition, and aluminium toxicity in people on dialysis. It is used by injection into a muscle, vein, or under the skin.

Common side effects include pain at the site of injection, diarrhea, vomiting, fever, hearing loss, and eye problems. Severe allergic reactions including anaphylaxis and low blood pressure may occur. It is unclear if use during pregnancy or breastfeeding is safe for the baby. Deferoxamine is a siderophore from the bacteria Streptomyces pilosus.

Deferoxamine was approved for medical use in the United States in 1968. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is about US$6.76 to $13.52 per dose. In the United States a course of treatment costs more than $200.